Publication | Closed Access

Design, synthesis, biological evaluation and molecular docking study of arylcarboxamido piperidine and piperazine-based hydroxamates as potential HDAC8 inhibitors with promising anticancer activity

Medicinal ChemistryPotential Hdac8 InhibitorsBiochemistryMedicineNatural SciencesRational Drug DesignArylcarboxamido PiperidinePharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyMolecular Docking StudyDrug Discovery